EyePoint Pharmaceuticals
EYPT
EYPT
61 hedge funds and large institutions have $97.2M invested in EyePoint Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 5.8% → 5.8% (+0%)
13% less capital invested
Capital invested by funds: $111M → $97.2M (-$14M)
Holders
61
Holding in Top 10
1
Calls
$211K
Puts
$143K
Top Buyers
| 1 | +$470K | |
| 2 | +$310K | |
| 3 | +$153K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$148K |
| 5 |
Morgan Stanley
New York
|
+$102K |
Top Sellers
| 1 | -$150K | |
| 2 | -$65K | |
| 3 | -$47.7K | |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$47K |
| 5 |
ACP
Arcus Capital Partners
Atlanta,
Georgia
|
-$45K |